TechRadar Pro created this content as part of a paid partnership with RS. The content of this article is entirely independent and solely reflects the editorial opinion of TechRadar Pro. Arduino turns ...
President Trump suggested in an interview with former FBI Deputy Director Dan Bongino on Monday that Republicans should “take over” the voting process in more than a dozen states ahead of the November ...
The original version of the UNO Q paired Qualcomm’s Dragonwing QRB2210 processor with 2GB of RAM and 16GB of storage. A little over three months after it was announced alongside Qualcomm’s acquisition ...
Ubisoft in a 2025 corporate press kit has revealed the sales figures and player counts for a number of its franchises. The Tom Clancy's Ghost Recon series with over 40 million units, while Ghost Recon ...
What if you could combine the simplicity of Arduino with the power of a Linux-based processor, all in one compact device? Enter the Arduino Uno Q, a new development board designed to handle everything ...
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why. Researchers found that inflammation in the brain disrupts the energy supply of ...
2025 would go down in history as a good year for equities, but also a period when certain risks became apparent. Supportive macroeconomic conditions will likely remain in 2026 and so far there are no ...
There's more to watch than ever before, but perhaps you still find yourself idly flicking through the “What's New” carousel on Netflix and not seeing anything that really grabs you … so then you do ...
Sanofi SAN1.54%increase; green up pointing triangle shares fell after an experimental treatment for multiple sclerosis was hit by a double setback, with results of a late-stage study missing a key ...
Some members of the maker community are distraught about Arduino’s new terms of service (ToS), saying that the added rules put the company’s open source DNA at ...
For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition develops into multiple myeloma. The FDA has approved Johnson & Johnson’s ...
When Jean Kay started a brand-new multiple sclerosis treatment called Rebif in 2003, it cost $17,500 a year. That was pricey, but her insurance covered most of it, and the drug slowed the disease’s ...